Skip to Content

2 mg ETH267 (Doxazosin Mesylate 2 mg)

Pill with imprint 2 mg ETH267 is Yellow, Elliptical / Oval and has been identified as Doxazosin Mesylate 2 mg. It is supplied by Ethex Corporation.

Doxazosin is used in the treatment of benign prostatic hyperplasia; raynaud's syndrome; high blood pressure and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Doxazosin 2 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 2 mg ETH267

Doxazosin Mesylate

Imprint
2 mg ETH267
Strength
2 mg
Color
Yellow
Size
9.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Antiadrenergic agents, peripherally acting
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Ethex Corporation
National Drug Code (NDC)
58177-0267

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.